BMX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Biomaxima SA operates in the field of biotechnology and laboratory diagnostics. It offers diagnostic reagents to study biochemical parameters of blood and other body fluids including analyzers, rapid diagnostic tests for the detection of infectious diseases, tumor markers, markers of myocardial infarction, and drugs. The firm also produces systems for analyzing urine, hematology reagents, and blood analyzers. The company was founded in 1997 and is headquartered in Lublin, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
BMX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company